Documentaries, videos and podcasts
Continental Who's Who
May 28, 2021
/PRNewswire/ -- Kathleen Harper, DO, FACC, FACP is being recognized by Continental Who's Who as a Top Cardiologist for her outstanding achievements in...
May 17, 2021
More than quoting statistics and pointing to gaps, the all-female commission set out 10 recommendations for meaningful change.
Stealth BioTherapeutics Inc.
May 17, 2021
/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and...
April 27, 2021
The TRANSFORM studies will deliver guideline recommendations through the EHR system while monitoring heart patients' care and outcomes. The first of three studies is set to begin in the coming weeks.
April 22, 2021
VAZKEPA (icosapent ethyl) is the first and only authorized treatment for its cardiovascular risk reduction indication 1,2, 3 VAZKEPA authorization for Great Britain follows recent VAZKEPA authorization for European Union
National Kidney Foundation
April 9, 2021
/PRNewswire/ -- Each year the National Kidney Foundation (NKF) considers the work of hundreds of specialists, advocates and volunteers in the field of...
April 2, 2021
Complications and the Influence of COVID-19 on Myocardial Function and Exercise Capacity - Full Text View.
American College of Cardiology
December 15, 2020
/PRNewswire/ -- The American College of Cardiology, in collaboration with Amgen and Veradigm, today announced a new national study to transform care for acute...
December 2, 2020
A case report from the United States reveals how a two-month-old infant who was turning blue had been infected by the coronavirus.
December 1, 2020
LUCA Science (Tokyo, Japan), a biotechnology company pioneering a novel class of mitochondrial therapeutics, announced today that it will collaborate with the Division of Cardiology, Field of Internal Medicine, Nagoya University Graduate School of Medicine to initiate a joint research on the development of mitochondrial therapy for cardiac ischemic-reperfusion injury.
November 19, 2020
Lockdown due to the COVID-19 pandemic is associated with an increase in high blood pressure among patients admitted to emergency. That's the finding of a study presented at the 46th Argentine Congress of Cardiology (SAC). SAC 2020 is a virtual meeting during 19 to 21 November. Faculty from the European Society of Cardiology (ESC) will participate in joint scientific sessions with the Argentine Society of Cardiology as part of the ESC Global Activities programme. "Admission to the emerge...
November 13, 2020
Trial Met Primary Composite Endpoint of Reduction in Heart Failure Events or Cardiovascular Death; Did Not Meet Secondary Endpoints Including Reduction in Cardiovascular Death Effect of Omecamtiv Mecarbil Consistent Across Most Prespecified Subgroups with Potentially Greater Treatment Effect in Patients with Lower Ejection Fraction at Higher Risk Cytokinetics to Host Investor/Media Event and Webcast on
November 13, 2020
CMR Findings in COVID-19 Patients Presenting With Myocardial Infarction - Full Text View.
November 11, 2020
MyoKardia, Inc. (NASDAQ: MYOK), and the American College of Cardiology (ACC) announced the establishment of a nationwide registry of hypertrophic cardiomyopathy (HCM), which leverages the ACC's PINNACLE Cardiovascular Registry operated by Veradigm®, an Allscripts (NASDAQ: MDRX), business unit. The registry will support MyoKardia's post-marketing safety and effectiveness study (DISCOVER-HCM) of mavacamten, an investigational the
November 10, 2020
Findings from a randomized controlled trial recently published in the Journal of the American College of Cardiology, indicate that people in their 60s and 70s who regularly consume walnuts may have reduced inflammation, a factor associated with a lower risk of heart disease, compared to those who do not eat walnuts.
August 24, 2020
Yoga postures and breathing could help patients with atrial fibrillation manage their symptoms, according to research presented today at ESC Congress 2020.1 Atrial fibrillation is the most common heart rhythm disorder. One in four middle-aged adults in Europe and the US will develop the condition, which causes 20-30% of all strokes and increases the risk of death by 1.5-fold in men and 2-fold in women. Reduced quality of life is common, and 10-40% of patients are hospitalised each year.2...
March 21, 2020
The Times of India
A new study has thrown light on how stress and mental pressure can trigger a second heart attack in patients. We all have stress in our lives--whether it's due to financial woes, work pressures, relationship issues, illness or even natural disasters
January 21, 2020
Review recommends patients at risk of cardiovascular events should be counseled to avoid or minimize marijuana use until further data are available. As more states legalize marijuana for both medicinal and recreational use and use increases nationwide, cardiologists should advise patients about t
December 25, 2019
Structured cardiac rehabilitation the need of the hour
November 22, 2019
Insufficient sleep is one reason why disadvantaged groups have more heart disease. That's the finding of a study published today in Cardiovascular Research, a journal of the European Society of Cardiology (ESC).1 People with lower socioeconomic status sleep less for a variety of reasons: they may do several jobs, work in shifts, live in noisy environments, and have greater levels of emotional and financial stress. This was the first large population-based study to examine whether lack...
Be the first contributor by making edits